Clinical Trial Update: A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TransCon hGH weekly versus daily hGH in children with growth hormone deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency Pediatric

Drugs mentioned

• TransCon hGH (somatropin)
• hGH (human growth hormone)

Snippet

Sponsor: Ascendis Pharma Endocrinology Division A/S | Conditions: Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone) | Phase 3 | Status: COMPLETED | Results posted: 2022-01-04